MedTrace Logo

PET Study in Multiple Sclerosis

NCT03787446 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2019-04-22

No results posted yet for this study

Summary

While both conventional and advanced MRI techniques offer important insights into MS pathophysiology, important aspects of this inflammatory disorder are undetectable with existing MRI technology. In Multiple Sclerosis (MS), there is growing interest in PET as an imaging modality that can increase the investigator's understanding of the disease processes and may add to an understanding of MS phenotype, particularly when combined with advanced MRI techniques such as myelin water imaging.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Robert L Carruthers, MD · MS Clinical Trials Group

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-26
Primary Completion
2020-03-31
Completion
2020-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03787446 on ClinicalTrials.gov